CALIFORNIA BANCORP (BCAL) Fundamental Analysis & Valuation

NASDAQ:BCAL • US84252A1060

Current stock price

18.36 USD
-0.02 (-0.11%)
At close:
18.36 USD
0 (0%)
After Hours:

This BCAL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BCAL Profitability Analysis

1.1 Basic Checks

  • In the past year BCAL was profitable.
  • BCAL had a positive operating cash flow in the past year.
  • In the past 5 years BCAL has always been profitable.
  • Each year in the past 5 years BCAL had a positive operating cash flow.
BCAL Yearly Net Income VS EBIT VS OCF VS FCFBCAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 50M 100M

1.2 Ratios

  • BCAL has a better Return On Assets (1.56%) than 88.06% of its industry peers.
  • BCAL has a better Return On Equity (10.94%) than 68.17% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.55%, BCAL belongs to the top of the industry, outperforming 99.47% of the companies in the same industry.
  • BCAL had an Average Return On Invested Capital over the past 3 years of 2.02%. This is in line with the industry average of 2.71%.
  • The last Return On Invested Capital (2.55%) for BCAL is above the 3 year average (2.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.56%
ROE 10.94%
ROIC 2.55%
ROA(3y)0.93%
ROA(5y)0.8%
ROE(3y)7%
ROE(5y)6.3%
ROIC(3y)2.02%
ROIC(5y)1.55%
BCAL Yearly ROA, ROE, ROICBCAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • BCAL's Profit Margin of 27.83% is fine compared to the rest of the industry. BCAL outperforms 62.60% of its industry peers.
  • In the last couple of years the Profit Margin of BCAL has grown nicely.
  • BCAL has a Operating Margin of 65.24%. This is amongst the best in the industry. BCAL outperforms 99.47% of its industry peers.
  • BCAL's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 65.24%
PM (TTM) 27.83%
GM N/A
OM growth 3Y20.25%
OM growth 5YN/A
PM growth 3Y17.51%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCAL Yearly Profit, Operating, Gross MarginsBCAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BCAL Health Analysis

2.1 Basic Checks

  • BCAL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BCAL has more shares outstanding than it did 1 year ago.
  • BCAL has a better debt/assets ratio than last year.
BCAL Yearly Shares OutstandingBCAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M
BCAL Yearly Total Debt VS Total AssetsBCAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of -0.66, we must say that BCAL is in the distress zone and has some risk of bankruptcy.
  • BCAL has a better Altman-Z score (-0.66) than 98.94% of its industry peers.
  • The Debt to FCF ratio of BCAL is 59.79, which is on the high side as it means it would take BCAL, 59.79 years of fcf income to pay off all of its debts.
  • BCAL's Debt to FCF ratio of 59.79 is on the low side compared to the rest of the industry. BCAL is outperformed by 88.06% of its industry peers.
  • A Debt/Equity ratio of 5.90 is on the high side and indicates that BCAL has dependencies on debt financing.
  • BCAL has a worse Debt to Equity ratio (5.90) than 96.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.9
Debt/FCF 59.79
Altman-Z -0.66
ROIC/WACC0.76
WACC3.34%
BCAL Yearly LT Debt VS Equity VS FCFBCAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.3 Liquidity

  • BCAL has a Current Ratio of 0.03. This is a bad value and indicates that BCAL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of BCAL (0.03) is better than 98.94% of its industry peers.
  • A Quick Ratio of 0.03 indicates that BCAL may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.03, BCAL belongs to the top of the industry, outperforming 98.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
BCAL Yearly Current Assets VS Current LiabilitesBCAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BCAL Growth Analysis

3.1 Past

  • BCAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 164.38%, which is quite impressive.
  • Measured over the past years, BCAL shows a very strong growth in Earnings Per Share. The EPS has been growing by 28.86% on average per year.
  • Looking at the last year, BCAL shows a very strong growth in Revenue. The Revenue has grown by 26.48%.
  • Measured over the past years, BCAL shows a very strong growth in Revenue. The Revenue has been growing by 34.11% on average per year.
EPS 1Y (TTM)164.38%
EPS 3Y28.86%
EPS 5YN/A
EPS Q2Q%-1.96%
Revenue 1Y (TTM)26.48%
Revenue growth 3Y34.11%
Revenue growth 5YN/A
Sales Q2Q%5.04%

3.2 Future

  • Based on estimates for the next years, BCAL will show a decrease in Earnings Per Share. The EPS will decrease by -1.83% on average per year.
  • BCAL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.91% yearly.
EPS Next Y-13.47%
EPS Next 2Y-1.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.22%
Revenue Next 2Y3.91%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BCAL Yearly Revenue VS EstimatesBCAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
BCAL Yearly EPS VS EstimatesBCAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. BCAL Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.51, the valuation of BCAL can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of BCAL indicates a rather cheap valuation: BCAL is cheaper than 87.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.18, BCAL is valued rather cheaply.
  • BCAL is valuated reasonably with a Price/Forward Earnings ratio of 10.99.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BCAL.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.96, BCAL is valued rather cheaply.
Industry RankSector Rank
PE 9.51
Fwd PE 10.99
BCAL Price Earnings VS Forward Price EarningsBCAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BCAL indicates a rather cheap valuation: BCAL is cheaper than 99.20% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BCAL is valued a bit cheaper than 69.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.42
EV/EBITDA 3.75
BCAL Per share dataBCAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • BCAL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.83%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. BCAL Dividend Analysis

5.1 Amount

  • BCAL has a Yearly Dividend Yield of 2.16%.
  • Compared to an average industry Dividend Yield of 2.53, BCAL is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.82, BCAL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

  • BCAL is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
BCAL Yearly Dividends per shareBCAL Yearly Dividends per shareYearly Dividends per share 2025 2026 0.02 0.04 0.06 0.08

5.3 Sustainability

  • BCAL pays out 5.16% of its income as dividend. This is a sustainable payout ratio.
DP5.16%
EPS Next 2Y-1.83%
EPS Next 3YN/A
BCAL Yearly Income VS Free CF VS DividendBCAL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 20M 40M 60M
BCAL Dividend Payout.BCAL Dividend Payout, showing the Payout Ratio.BCAL Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BCAL Fundamentals: All Metrics, Ratios and Statistics

CALIFORNIA BANCORP

NASDAQ:BCAL (4/13/2026, 8:10:14 PM)

After market: 18.36 0 (0%)

18.36

-0.02 (-0.11%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-28
Earnings (Next)04-23
Inst Owners64.8%
Inst Owner Change0%
Ins Owners23.89%
Ins Owner Change-0.88%
Market Cap593.58M
Revenue(TTM)226.56M
Net Income(TTM)63.06M
Analysts84.44
Price Target21.93 (19.44%)
Short Float %1.81%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP5.16%
Div Incr Years0
Div Non Decr Years1
Ex-Date03-24
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.62%
Min EPS beat(2)13.3%
Max EPS beat(2)19.95%
EPS beat(4)4
Avg EPS beat(4)16.09%
Min EPS beat(4)3.66%
Max EPS beat(4)27.45%
EPS beat(8)6
Avg EPS beat(8)8.63%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.07%
Max Revenue beat(2)1.07%
Revenue beat(4)1
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-3.08%
Max Revenue beat(4)1.07%
Revenue beat(8)1
Avg Revenue beat(8)-2.82%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.71%
EPS NY rev (1m)-0.61%
EPS NY rev (3m)-5.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.45%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)-2.24%
Valuation
Industry RankSector Rank
PE 9.51
Fwd PE 10.99
P/S 2.62
P/FCF 10.42
P/OCF 10.36
P/B 1.03
P/tB 1.33
EV/EBITDA 3.75
EPS(TTM)1.93
EY10.51%
EPS(NY)1.67
Fwd EY9.1%
FCF(TTM)1.76
FCFY9.59%
OCF(TTM)1.77
OCFY9.65%
SpS7.01
BVpS17.83
TBVpS13.83
PEG (NY)N/A
PEG (5Y)N/A
Graham Number27.83
Profitability
Industry RankSector Rank
ROA 1.56%
ROE 10.94%
ROCE 24.21%
ROIC 2.55%
ROICexc 2.59%
ROICexgc 2.72%
OM 65.24%
PM (TTM) 27.83%
GM N/A
FCFM 25.13%
ROA(3y)0.93%
ROA(5y)0.8%
ROE(3y)7%
ROE(5y)6.3%
ROIC(3y)2.02%
ROIC(5y)1.55%
ROICexc(3y)2.05%
ROICexc(5y)1.57%
ROICexgc(3y)2.15%
ROICexgc(5y)1.64%
ROCE(3y)20.26%
ROCE(5y)15.75%
ROICexgc growth 3Y33.61%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.92%
ROICexc growth 5YN/A
OM growth 3Y20.25%
OM growth 5YN/A
PM growth 3Y17.51%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 5.9
Debt/FCF 59.79
Debt/EBITDA 22.19
Cap/Depr 6.16%
Cap/Sales 0.15%
Interest Coverage 2.53
Cash Conversion 37.34%
Profit Quality 90.3%
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -0.66
F-Score7
WACC3.34%
ROIC/WACC0.76
Cap/Depr(3y)12.36%
Cap/Depr(5y)38.57%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.88%
Profit Quality(3y)377.47%
Profit Quality(5y)275.14%
High Growth Momentum
Growth
EPS 1Y (TTM)164.38%
EPS 3Y28.86%
EPS 5YN/A
EPS Q2Q%-1.96%
EPS Next Y-13.47%
EPS Next 2Y-1.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.48%
Revenue growth 3Y34.11%
Revenue growth 5YN/A
Sales Q2Q%5.04%
Revenue Next Year1.22%
Revenue Next 2Y3.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.64%
EBIT growth 3Y61.27%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.48%
FCF growth 3Y66.8%
FCF growth 5YN/A
OCF growth 1Y13.91%
OCF growth 3Y62.5%
OCF growth 5YN/A

CALIFORNIA BANCORP / BCAL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CALIFORNIA BANCORP?

ChartMill assigns a fundamental rating of 5 / 10 to BCAL.


What is the valuation status for BCAL stock?

ChartMill assigns a valuation rating of 6 / 10 to CALIFORNIA BANCORP (BCAL). This can be considered as Fairly Valued.


What is the profitability of BCAL stock?

CALIFORNIA BANCORP (BCAL) has a profitability rating of 7 / 10.


Can you provide the financial health for BCAL stock?

The financial health rating of CALIFORNIA BANCORP (BCAL) is 3 / 10.


Can you provide the dividend sustainability for BCAL stock?

The dividend rating of CALIFORNIA BANCORP (BCAL) is 2 / 10 and the dividend payout ratio is 5.16%.